Witness the construction of the research and development facility for the world leader in the treatment of opioid addiction, Indivior in just 2 minutes with this official time-lapse movie. With a scope of work encompassing groundwork, piling, shell construction and the internal specialist architectural fit out of cleanrooms and laboratories. The two-storey cGMP facility provides 5,000 square metres of ISO7 and ISO8 product development cleanrooms and laboratories, along with highly specified offices, meeting rooms and a restaurant for staff.
BES are delighted to have been selected to undertake the full design up to RIBA stage 4 of a new multimillion pound production facility for a world-leading medical equipment manufacturer. Our client specialises in advanced wound management and surgical devices and this investment will allow and support the company's growth. The client's existing manufacturing process is at the end of its serviceable life and must be replaced to ensure a continued supply of adhesive used in their wound management products. The process is also extremely operator-intensive with many time consuming activities.
We are delighted to announce that Steve Marsh, Managing Director and founder of BES, was named Business Person of the Year at the Rochdale Business Awards hosted at Rochdale Town Hall on 10th November, 2017.
Our project team, along with AstraZeneca's site team, recently celebrated 500,000 hours safely worked on the Macclesfield Packing and Logistics Project. Congratulations on reaching this great milestone!
We are celebrating after winning the Contractor of the Year Award at the inaugural National Building Engineering Services Association (BESA). By working in a close collaboration with AstraZeneca, we delivered a highly sophisticated facility, which has been hailed as a major success. Hosted on October 19, 2017, at the Park Plaza Hotel, London, the awards celebrated the best in the building services industry across the UK.
BES have successfully completed the full turnkey delivery from initial concept through to detailed design, construction and fit-out of a state of the art laboratory facility within an existing R&D development for a leading Bio-pharmaceutical Contract Development & Manufacturing Organisation (CDMO).
After seeing the success of using BIM technology in our projects over recent years, BES have decided to go one step further and integrate the latest virtual reality (VR) design platform to move away from traditional modelling and create something that is more user-friendly and more accessible to our clients.
BES have successfully completed both concept and detailed design for the refurbishment of an existing warehouse facility to form a new clinical trial therapeutic protein manufacturing facility for a large blue chip pharmaceutical manufacturer based in the North East.
BES has completed the construction phase of a £13 million project for global pharmaceutical business and world leader in the treatment of opioid addiction, Indivior. The new research and development (R&D) facility will be used to test and manufacture a non-addictive alternative to methadone, in order to improve patient experience on a global scale.
We have recently appointed healthcare construction expert, Gavin Statham as business development director. The company has experienced rapid business growth over the last two years and has relocated to larger offices to facilitate further expansion and increasing demand. In his new role, Gavin will develop the BES brand further, allowing it to accelerate its continued expansion and improve its client base.